Drug Profile


Alternative Names: N 547; Niacinamide; Nicotinamide gel; Papulex

Latest Information Update: 03 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GenDerm Corporation; National Institutes of Health (USA); University of Washington
  • Developer Euroderma; GenDerm Corporation; University of Washington
  • Class Amides; Antiacnes; Antibacterials; Nicotinic-acids; Small molecules; Vitamins
  • Mechanism of Action Cytokine modulators; JNK mitogen-activated protein kinase inhibitors; Leukocyte modulators; Mitogen-activated protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris
  • Discontinued Type 1 diabetes mellitus

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 26 Nov 2015 Alliance Pharma plc enters into a conditional agreement to acquire Nicotinamide from Sinclair IS Pharma plc
  • 11 Nov 2011 Invida Group has been acquired by Menarini
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top